ResearcherShaanxi Provincial People's HospitalActive in the last 2 years

Xiaoyan Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9388-484X; OpenAlex author ID A5072301682. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer. Co-author DOI 10.1002/jmv.29809 ↗
Suppression of rhomboid domain-containing 1 produces anticancer effects in pancreatic adenocarcinoma through affection of the AKT/GSK-3β/β-catenin pathway. Last author DOI 10.1002/tox.23541 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiong Jiang · 2 shared papers, 2022–2024 · strength 0.35
- Paper Suppression of rhomboid domain-containing 1 produces anticancer effects in pancreatic adenocarcinoma through affection … DOI 10.1002/tox.23541 ↗
- Paper Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer. DOI 10.1002/jmv.29809 ↗
Pan Zhang · 1 shared paper, 2024 · strength 0.15
- Paper Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer. DOI 10.1002/jmv.29809 ↗
Ting Wang · 1 shared paper, 2024 · strength 0.15
- Paper Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer. DOI 10.1002/jmv.29809 ↗
Shiyang Ma · 1 shared paper, 2024 · strength 0.15
- Paper Metagenomic analysis reveals altered gut virome and diagnostic potential in pancreatic cancer. DOI 10.1002/jmv.29809 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.